Published in J Immunol on June 15, 1998
Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun (1998) 1.87
Ocular immune privilege. Eye (Lond) (2009) 1.45
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol (2008) 1.23
Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med (2001) 1.16
What causes alopecia areata? Exp Dermatol (2013) 1.14
Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog (2010) 1.10
Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas. Infect Immun (2005) 1.07
Immune escape mechanisms of intraocular tumors. Prog Retin Eye Res (2009) 1.07
Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. J Clin Biochem Nutr (2012) 1.04
TLRs and NODs mRNA expression pattern in healthy mouse eye. Br J Ophthalmol (2005) 1.03
Immune privilege of corneal allografts. Ocul Immunol Inflamm (2010) 1.01
Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology (2000) 0.99
Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J Ocul Biol Dis Infor (2008) 0.98
Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis. Biochem J (2001) 0.94
Sertoli cell-specific deletion of the androgen receptor compromises testicular immune privilege in mice. Biol Reprod (2011) 0.93
Influence of CD8+ T regulatory cells on intraocular tumor development. Front Immunol (2012) 0.92
Corneal transplantation and immune privilege. Int Rev Immunol (2013) 0.91
MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol (2009) 0.91
Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? Front Immunol (2012) 0.90
The differential effect of stress on natural killer T (NKT) and NK cell function. Clin Exp Immunol (2000) 0.89
Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect (1999) 0.89
Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis. Invest Ophthalmol Vis Sci (2008) 0.88
Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin Immunopathol (2006) 0.85
Retinal laser burn disrupts immune privilege in the eye. Am J Pathol (2009) 0.85
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. J Immunol (2008) 0.85
Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts. PLoS One (2013) 0.84
Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells. J Ocul Pharmacol Ther (2014) 0.83
Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp Eye Res (2007) 0.83
Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm (2010) 0.81
Cornea: Window to Ocular Immunology. Curr Immunol Rev (2011) 0.81
Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR. J Virol (2001) 0.81
Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta. Reprod Biol Endocrinol (2010) 0.81
The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface. Semin Immunopathol (2007) 0.81
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models. Int J Oncol (2014) 0.80
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation. Clin Exp Immunol (2000) 0.80
Ocular Immune Privilege and Transplantation. Front Immunol (2016) 0.80
Alloimmunity and Tolerance in Corneal Transplantation. J Immunol (2016) 0.79
Role of inflammation in endophthalmitis. Mediators Inflamm (2012) 0.78
Macrophage migration inhibitory factor in ocular fluids of patients with uveitis. Br J Ophthalmol (2001) 0.78
Role of NKT cells in anterior chamber-associated immune deviation. Expert Rev Clin Immunol (2009) 0.77
NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases. Int J Cancer (2015) 0.77
Murine corneal transplantation: a model to study the most common form of solid organ transplantation. J Vis Exp (2014) 0.77
High-risk corneal allografts: A therapeutic challenge. World J Transplant (2016) 0.75
Expression of MIF and c-erbB-2 in endometrial cancer. Mol Med Rep (2016) 0.75
Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res (2000) 3.12
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Gene sharing by delta-crystallin and argininosuccinate lyase. Proc Natl Acad Sci U S A (1988) 2.07
Enzyme/crystallins: gene sharing as an evolutionary strategy. Cell (1989) 2.03
Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci U S A (2000) 1.83
The enzyme lactate dehydrogenase as a structural protein in avian and crocodilian lenses. Nature (1987) 1.68
Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 1.63
Falling between two stools: operational inconsistencies between ICDS and NRHM in the management of severe malnutrition. Indian Pediatr (2012) 1.58
The P23T cataract mutation causes loss of solubility of folded gammaD-crystallin. J Mol Biol (2004) 1.53
Cellular electrophoretic mobility and the mitotic cycle. J Gen Physiol (1966) 1.51
Oral immunisation as a strategy for enhancing corneal allograft survival. Br J Ophthalmol (1997) 1.51
Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci (1993) 1.41
Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol (2002) 1.40
Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol (1985) 1.38
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res (1992) 1.38
Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci (1991) 1.34
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study. Br J Cancer (2007) 1.30
A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol (1998) 1.30
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. J Biol Chem (1992) 1.29
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology (1998) 1.23
Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci (2001) 1.21
In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest Ophthalmol Vis Sci (1990) 1.21
Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med (1980) 1.21
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci (1984) 1.19
Role of antibody and complement in the control of Encephalitozoon cuniculi infections by rabbit macrophages. Infect Immun (1980) 1.19
In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. Cancer Lett (1993) 1.19
Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun (1998) 1.17
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer (1993) 1.16
The complete sequence of the chicken delta 1 crystallin gene and its 5' flanking region. J Biol Chem (1985) 1.15
Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood (1985) 1.13
Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi. Clin Exp Immunol (1984) 1.13
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res (1976) 1.12
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer (1992) 1.11
mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci U S A (1992) 1.11
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10
Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol (2001) 1.10
Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer (1982) 1.09
The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1996) 1.08
Increased ouabain-sensitive 86Rb+ uptake and sodium and potassium ion-activated adenosine triphosphatase activity in transformed cell lines. J Biol Chem (1975) 1.08
Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol (1982) 1.08
Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. Biochim Biophys Acta (1974) 1.08
Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer (1984) 1.07
Antigenic cross-reactivity among different microsporidan spores as determined by immunofluorescence. J Parasitol (1980) 1.06
Bayesian semiparametric models for survival data with a cure fraction. Biometrics (2001) 1.05
Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci (1995) 1.05
Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant (2009) 1.04
Susceptibility of selected inbred strains of mice to Encephalitozoon cuniculi. J Infect Dis (1981) 1.04
The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1993) 1.04
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer (1997) 1.04
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol (2000) 1.03
Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res (1992) 1.03
βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis. Cell Death Dis (2011) 1.03
The effect of polycations on cell membrane stability and transport processes. J Membr Biol (1973) 1.03
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J Immunol (1987) 1.03
Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J Immunol (1983) 1.02
Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect Immun (1994) 1.02
Cellular uptake and protection against virus infection by polyinosinic-polycytidylic acid entrapped within phospholipid vesicles. Mol Pharmacol (1977) 1.02
Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy. Indian J Nephrol (2013) 1.01
The cDNA RPE1 and monoclonal antibody HMB-50 define gene products preferentially expressed in retinal pigment epithelium. Exp Eye Res (1992) 1.01
Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest (1984) 1.00
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res (1993) 1.00
Ribonuclease-susceptible charged groups at the surface of Ehrlich ascites tumour cells. Int J Cancer (1969) 0.99
Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int J Cancer (1993) 0.99
Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transplantation (1982) 0.99
Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J Biol Chem (1999) 0.99
Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res (1983) 0.99
Developmental abnormalities in the Nuc1 rat retina: a spontaneous mutation that affects neuronal and vascular remodeling and retinal function. Neuroscience (2005) 0.98
The nature of estrogen and prolactin effect on mammary tumorigenesis. Cancer Res (1973) 0.98
Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol (2001) 0.98
The effect of oral immunization on corneal allograft survival. Transplantation (1996) 0.97
Acanthamoeba keratitis. CLAO J (1995) 0.96
Sequence analysis of bovine retinal S-antigen. Relationships with alpha-transducin and G-proteins. FEBS Lett (1986) 0.96
Cellular binding of 3H-cytochalasin B. J Cell Physiol (1974) 0.96
Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea (2001) 0.96
Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities. Anticancer Drugs (2001) 0.96
Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur J Immunol (1995) 0.95
The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci (2000) 0.95
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol (1995) 0.95
Selective therapy of metastasis. I. Quantitation of tumorigenic circulating and covert cancer cells disseminated from metastatic and nonmetastatic tumors. Cancer Drug Deliv (1984) 0.94
Expression of duck lens delta-crystallin cDNAs in yeast and bacterial hosts. Delta 2-crystallin is an active argininosuccinate lyase. J Biol Chem (1991) 0.94
The diagnosis and management of Acanthamoeba keratitis. CLAO J (2000) 0.94
Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol (2010) 0.93
Targeted drug delivery. Cancer (1986) 0.93
A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci (1992) 0.93
Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. Drug Metab Dispos (1979) 0.93
Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat Rep (1980) 0.93
Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol (1996) 0.93
Interactions of La2+ with phosphatidylserine vesicles: binding, phase transition, leakage, 31P-NMR and fusion. Biochim Biophys Acta (1981) 0.93
Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1998) 0.93
Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology (1996) 0.93
Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul Immunol Inflamm (1997) 0.92
Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. J Biol Chem (1985) 0.92